A new paper published in Nature shows how, in a collaborative project across diverse medical disciplines, Oxford researchers from NDCN and the Department of Biochemistry have identified a new genetic link to pain.
A research project led jointly by researchers from NDCN, the University of Copenhagen and University of Cambridge shows that large-scale mapping of prehistoric teeth and bones provides new knowledge of present-day infectious diseases. This may, among other things, have an impact on the development of vaccines.
Claire Bergstrom Johnson, a DPhil Clarendon Scholar at the Nuffield Department of Clinical Neurosciences, has been awarded the highly prestigious 2025 Benson Research Fellowship by the GBS|CIDP Foundation International - one of the most competitive fellowships for early-career researchers in peripheral nerve research.\r\n\r\nWe spoke with Claire about the personal journey that inspired her to pursue this field, and how the three-year, $450,000 fellowship will support her ongoing work and future discoveries.
A new Medical Research Council Centre of Research Excellence (MRC CoRE) aims to develop brain stimulation devices to treat conditions such as Parkinson\u2019s, dementia, stroke and childhood epilepsy.
Congratulations to the NDCN Green Impact team who have relaunched this year, earning a bronze award for their work to improve sustainability within the department.
As part of its renewed commitment, the Alan Davidson Foundation will continue to fund a full-time project manager to facilitate the ongoing coordination and growth of the ACORN study. The foundation is also contributing to the cost of a research fellow to support the next phase of the project.
Patrick Oliver, a final year medical student at Oxford, has worked with Oxford Parkinson\u2019s Disease Centre to get a first author publication on a new review of the gut brain axis in Parkinson\u2019s disease.
Our annual event where we join together to celebrate our people and the work of our Department over the last year. Nearly 200 staff and students came together for this year's event on Wednesday 11 June at the Mathematical Institute.
A long-term clinical study has confirmed the effectiveness of a neuromodulatory treatment for severe focal seizures in both children and adults with drug-resistant epilepsy (DRE) and demonstrated the therapy\u2019s lasting impact.
The Vice-Chancellor\u2019s Awards, which recognise achievements and celebrate success across the collegiate University, were announced at a special ceremony hosted by the VC in the Sheldonian Theatre on 15 May 2025.
The findings shed new light on how the body\u2019s own defenses can mistakenly turn against the brain - and potentially opens the door to more targeted treatments.
A pioneering clinical trial for people with a sleep disorder who are at higher risk of developing Parkinson\u2019s has recruited its first UK participant from the Discovery Cohort study at the Oxford Parkinson\u2019s Disease Centre (OPDC)
![\"Cryo-EM](\"https://www.ndcn.ox.ac.uk/news/chronic-pain-research-breakthrough-identifies-promising-drug-target/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n